Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spine Asia CoROCO:6758 80 Days Payable is 14.74 as of Dec. 2025, which is 26% below its 10-year median of 20.01. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$48.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Spine Asia Co ranks worse than 96.98% on this metric.
The historical rank and industry rank for Spine Asia Co's Days Payable or its related term are showing as below:
ROCO:6758'
s Days Payable Range Over the Past 10 Years
Min: 13.5 Med: 20.01 Max: 86.25
Current: 14.52
During the past 10 years, Spine Asia Co's highest Days Payable was 86.25. The lowest was 13.50. And the median was 20.01.
ROCO:6758's Days Payable is ranked worse than 96.98% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ROCO:6758: 14.52
Spine Asia Co's Days Payable
declined
from Dec. 2024 (21.67) to Dec. 2025 (14.74).
It may suggest that Spine Asia Coaccelerated paying its suppliers.
Spine Asia Co Days Payable Related Terms
Spine Asia Co Days Payable Historical Data
* Premium members only.
The historical data trend for Spine Asia Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6758 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Spine Asia Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spine Asia Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spine Asia Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Spine Asia Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Spine Asia Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spine Asia Co (ROCO:6758) has a Days Payable of 14.74 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Spine Asia Co and its competitors. This is 26% below median its historical median of 20.01. Over the past decade, Spine Asia Co's Days Payable has ranged from 13.50 to 86.25. According to the industry distribution chart, Spine Asia Co ranks #771 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 97%.
Is Spine Asia Co's Days Payable too high?
Spine Asia Co's current Days Payable of 14.74 is 26% below median its 10-year median of 20.01. Over the past 10 years, this metric has ranged from a low of 13.50 to a high of 86.25. The Medical Devices & Instruments industry median Days Payable is 67.87. Spine Asia Co's value of 14.74 is 78.3% below this industry median. Based on the distribution chart, Spine Asia Co ranks #771 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spine Asia Co ranks #771 out of 795 companies for Days Payable. This places Spine Asia Co in the lower half of its industry. The industry median Days Payable is 67.87. Spine Asia Co's value of 14.74 is 78.3% below this benchmark. Historically, Spine Asia Co's own Days Payable has ranged from 13.50 to 86.25 over the past decade. While the company's 10-year median is 20.01 vs. the industry median of 67.87, Spine Asia Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spine Asia Co's current Days Payable of 14.74 is 78.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Spine Asia Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spine Asia Co's current Days Payable is 14.74, which is 26% below median its own 10-year median of 20.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$48.60, compared to a current price of NT$29.25 — trading 39.8% below its estimated fair value. The current Days Payable is 14.74, which is 26% below median its 10-year median of 20.01 and 78.3% below the Medical Devices & Instruments industry median of 67.87. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current Days Payable is 14.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spine Asia Co (ROCO:6758) Overvalued in 2026?
Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued.
The current stock price of NT$29.25 is trading 39.8% below its estimated GF Value™ of NT$48.60.
GuruFocus considers Spine Asia Co to be Significantly Undervalued.
Key valuation signals for ROCO:6758:
Days Payable: 14.74 (26% below median its 10-year median of 20.01)
GF Value™: NT$48.60 vs. price of NT$29.25 (39.8% below fair value)
Industry Position: 78.3% below the Medical Devices & Instruments median (#771 of 795)
No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score
Get the complete analysis for ROCO:6758
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6758 has been successfully added to your 
